Musculoskeletal Assessment Systems
Defines Aetna's coverage stance for computerized and wearable musculoskeletal assessment systems (e.g., Metrecom skeletal analysis, FIGUR8 Advanced Musculoskeletal Assessment System) for evaluation, screening, and rehabilitation. Applies to providers submitting claims for these systems and related CPT/ICD-10 codes.
No material clinical or coverage changes in this revision.
Coverage Determinations
Experimental and Investigational
Aetna considers the following experimental and investigational:
Individual components of these analyses are also considered experimental and investigational.
Individual components of computerized, biomechanical, or digital skeletal analyses are considered experimental and investigational. Aetna specifically notes that the value of these analyses in improving clinical outcomes has not been established, and therefore both the overall systems and their individual components are classified as experimental/investigational and not covered for the listed indications.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.